STOCKHOLM , March 21, 2025 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON) today reported financial results for the fiscal year ended December 31, 2024. FINANCIAL SUMMARY FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024: Revenues from continuing operations of $3.1 million, a decrease of 18.8% compared to the prior year.

Micron's Q2'25 earnings exceeded expectations due to strong demand for memory products, particularly HBM3E, and showed solid revenue growth in DRAM and NAND segments. The memory and storage company provided a positive outlook for Q3 with projected revenues of $8.8B, reflecting strong demand for memory, driven by Data Centers. HBM-related revenue crossed the $1.0B threshold in Q2'25 and the long term outlook for the memory market benefits Micron significantly.

Elon Musk tells Tesla employees to not sell their shares — Neutral
TSLA Proactive Investors — March 21, 2025Tesla Inc (NASDAQ:TSLA) CEO Elon Musk has told the company's employees to hold onto their stock following a 50% drop from its all-time high in December 2024. Tesla is facing multiple challenges, including slowing sales in key markets, and criticism related to Musk's role in the Trump administration and the CEO's focus on his other business ventures.

J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease — Positive
JNJ Zacks Investment Research — March 21, 2025FDA approves J&J's Tremfya for its fourth indication and the second IBD condition.

Oracle Up 18.4% in a Year: Buy, Sell or Hold the Stock? — Neutral
ORCL Zacks Investment Research — March 21, 2025Oracle shows strong cloud growth but high capex limits free cash flow. One can hold the stock if invested or wait for revenue acceleration from the $130B backlog.

Best Income Stocks to Buy for March 21st — Positive
CION FHB PFLT Zacks Investment Research — March 21, 2025CION, PFLT and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 21, 2025.

Archer Aviation (ACHR), Ford (F) and Iamgold (IAG) Are Intriguing Stocks Under $10 — Positive
ACHR F IAG 24/7 Wall Street — March 21, 2025Investing used to be a rich man's game, but over the years the stock market has been democratized.

Shareholders of Elastic N.V. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - ESTC — Neutral
ESTC Accesswire — March 21, 2025NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=137758&wire=1 or contact Joseph E.

Faruqi & Faruqi Reminds Skyworks Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - SWKS — Neutral
SWKS PRNewsWire — March 21, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Skyworks To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Skyworks between July 30, 2024 and February 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , March 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skyworks Solutions, Inc. ("Skyworks" …

Levi & Korsinsky Reminds Newmont Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 1, 2025 - NEM — Neutral
NEM Accesswire — March 21, 2025NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=137754&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on Grocery Outlet Holding Corp.(GO) should contact Levi & Korsinsky about pending Class Action - GO — Neutral
GO Accesswire — March 21, 2025NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=137757&wire=1 or contact Joseph E. Levi, Esq.

HealthEquity, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HQY — Neutral
HQY Accesswire — March 21, 2025NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, Inc. ("HealthEquity") (NASDAQ:HQY) concerning possible violations of federal securities laws. HealthEquity issued a press release on March 18, 2025, announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025.

Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
NTLA Accesswire — March 21, 2025EW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=137759&wire=1 or contact Joseph E. Levi, Esq.

Opus Genetics Announces Presentation on Phentolamine Ophthalmic Solution 0.75% in Dim Light Disturbances at World Cornea Congress IX — Neutral
IRD GlobeNewsWire — March 21, 2025RESEARCH TRIANGLE PARK, N.C., March 21, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic disorders, today announced that a presentation featuring the LYNX-1 Phase 3 study of Phentolamine Ophthalmic Solution 0.75% in patients with dim light disturbances will be delivered this week at World Cornea Congress IX, taking place March 20-22, 2025 in Washington, D.C.

Class Action Filed Against AppLovin Corporation (APP) - May 5, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
APP Accesswire — March 21, 2025NEW YORK, NY / ACCESS Newswire / March 21, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=137755&wire=1 or contact Joseph E. Levi, Esq.

Bonds have become more attractive in 2025 due to stock market volatility, with bond ETFs outperforming the S&P 500. The Pioneer High Income Fund focuses on sub-investment-grade bonds but has underperformed, with a 1.3% decline in 2025. PHT's risks include interest rate sensitivity, leverage, and sub-investment-grade exposure, with a current 7.05% discount to NAV.

ELF Investors Have Opportunity to Lead e.l.f. Beauty, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ELF PRNewsWire — March 21, 2025LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against e.l.f. Beauty, Inc. ("e.l.f.

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones — Neutral
CMND GlobeNewsWire — March 21, 2025Vancouver, Canada, March 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced today that its innovative drug candidate, CMND-100, has arrived in the United States following successful manufacturing. This marks a key milestone as the Company prepares to initiate its FDA-approved Phase I/IIa clinical trial for the treatment of Alcohol Use Disorder (AUD), a condition affecting over 28 million adults in the U.S. alone.

Diana Shipping Inc. Becomes Strategic Partner in Two 7,500 cbm Semi-Refrigerated LPG Newbuildings — Neutral
DSX GlobeNewsWire — March 21, 2025ATHENS, Greece, March 21, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that the Company agreed to become a strategic partner and invest in a newly established joint venture, Ecogas Holding AS, with an 80% equity interest in a transaction for the construction of two 7,500 cbm semi-refrigerated LPG newbuildings, with an option for two additional vessels. Delivery of the first vessel is expected in the first quarter of 2027 and of the second vessel in the fourth quarter of …

QUBT Investors Have Opportunity to Lead Quantum Computing Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
QUBT PRNewsWire — March 21, 2025LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quantum Computing Inc. ("Quantum Computing" or "the Company") (NASDAQ: QUBT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 30, 2020 and January 15, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 28, 2025.
